blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2015753

EP2015753 - PREVENTION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS [Right-click to bookmark this link]
Former [2009/04]INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS
[2012/48]
StatusPatent maintained as amended
Status updated on  23.09.2016
Database last updated on 20.11.2024
Most recent event   Tooltip03.02.2017Change - lapse in a contracting state
State(s) deleted from list of lapses: LV		published on 08.03.2017  [2017/10]
Applicant(s)For all designated states
The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services
Centers for Disease Control and Prevention, Technology Transfer Office, 4770 Buford Highway, MS K-79
Atlanta, Georgia 30341 / US
[2016/43]
Former [2009/04]For all designated states
The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services
Centers for Disease Control and Prevention, Technology Transfer Office, 4770 Buford Highway, MS K-79
Atlanta, Georgia 30341 / US
Inventor(s)01 / HENEINE, Walid
2830 Woodland Park Drive
Atlanta, GA 30345 / US
02 / FOLKS, Thomas
3815 Belle Glade Trail
Snellville, GA 30039 / US
03 / JANSSEN, Robert
106 Inman Circle
Altanta, GA 30309 / US
04 / OTTEN, Ronald
9795 Lakefall Ct.
Villa Rica, GA 30180 / US
05 / GARCIA-LERMA, J., Gerardo
1170 Larch Lane
Decatur, GA 30033 / US
 [2009/04]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/43]
Former [2014/33]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2013/18]Leissler-Gerstl, Gabriele, et al
Hoefer & Partner
Patentanwälte
Pilgersheimer Strasse 20
81543 München / DE
Former [2009/04]Leissler-Gerstl, Gabriele, et al
Hoefer & Partner Patentanwälte Pilgersheimer Strasse 20
81543 München / DE
Application number, filing date07763090.301.02.2007
[2009/04]
WO2007US02926
Priority number, dateUS20060764811P03.02.2006         Original published format: US 764811 P
US2007066954731.01.2007         Original published format: US 669547
[2009/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007092326
Date:16.08.2007
Language:EN
[2007/33]
Type: A2 Application without search report 
No.:EP2015753
Date:21.01.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2007 takes the place of the publication of the European patent application.
[2009/04]
Type: B1 Patent specification 
No.:EP2015753
Date:01.05.2013
Language:EN
[2013/18]
Type: B2 New European patent specification 
No.:EP2015753
Date:26.10.2016
Language:EN
[2016/43]
Search report(s)International search report - published on:US24.12.2008
(Supplementary) European search report - dispatched on:EP12.07.2011
ClassificationIPC:A61K45/06, A61K31/7072, A61K31/52, A61K31/505, A61K31/675, A61P31/18
[2012/48]
CPC:
A61K31/675 (EP,US); A61K31/513 (EP,US); A61K31/683 (EP,US);
A61K31/7072 (EP,US); A61K45/06 (EP,US); A61K9/0053 (US);
A61P31/18 (EP); A61K9/0034 (US) (-)
C-Set:
A61K31/7072, A61K2300/00 (EP,US);
A61K31/675, A61K2300/00 (US,EP)
Former IPC [2011/31]A61K31/52, A61K31/505, A61K31/675, A61P31/18, A61K45/06
Former IPC [2009/04]A61K31/52, A61K31/505, A61K31/675, A61P31/18
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/43]
Former [2009/04]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VORBEUGUNG VON HIV-INFEKTIONEN DURCH CHEMOPROPHYLAXE[2012/48]
English:PREVENTION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS[2012/48]
French:PREVENTION DE L'INFECTION PAR LE VIH PAR CHIMIOPROPHYLAXIE[2012/48]
Former [2009/04]HEMMUNG VON HIV-INFEKTIONEN DURCH CHEMOPROPHYLAXE
Former [2009/04]INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS
Former [2009/04]INHIBITION DE L'INFECTION PAR LE VIH PAR CHIMIOPROPHYLAXIE
Entry into regional phase03.09.2008National basic fee paid 
03.09.2008Search fee paid 
24.06.2009Designation fee(s) paid 
24.06.2009Examination fee paid 
Examination procedure24.06.2009Examination requested  [2009/32]
22.12.2011Amendment by applicant (claims and/or description)
11.12.2012Communication of intention to grant the patent
20.03.2013Fee for grant paid
20.03.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.12.2012
Opposition(s)Opponent(s)01  31.01.2014  05.02.2014  ADMISSIBLE
Generics [UK] Limited
(trading as Mylan)
Albany Gate
Darkes Lane
Potters Bar
Hertfordshire EN6 1AG / GB
Opponent's representative
FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
 [N/P]
Former [2015/48]
Opponent(s)01  31.01.2014  05.02.2014  ADMISSIBLE
Generics [UK] Limited
(trading as Mylan)
Albany Gate
Darkes Lane
Potters Bar
Hertfordshire EN6 1AG / GB
Opponent's representative
FRKelly
27 Clyde Road
Ballsbridge
Dublin 4 / IE
Former [2014/11]
Opponent(s)01  31.01.2014  05.02.2014  ADMISSIBLE
Generics [UK] Limited
(trading as Mylan)
Albany Gate
Darkes Lane
Potters Bar
Hertfordshire EN6 1AG / GB
Opponent's representative
Gallafent, Alison
Alison Gallafent Ltd
4 George Street
Llandeilo Dyfed
SA19 6AS / GB
10.03.2014Invitation to proprietor to file observations on the notice of opposition
22.09.2014Reply of patent proprietor to notice(s) of opposition
26.01.2016Legal effect of interlocutory decision in opposition
26.01.2016Date of oral proceedings
26.02.2016Despatch of interlocutory decision in opposition
26.02.2016Despatch of minutes of oral proceedings
15.06.2016Despatch of communication that the patent will be maintained as amended
14.09.2016Fee for printing new specification paid
Fees paidRenewal fee
02.03.2009Renewal fee patent year 03
16.02.2010Renewal fee patent year 04
25.02.2011Renewal fee patent year 05
15.02.2012Renewal fee patent year 06
12.02.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.02.2007
AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
TR01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
IE01.02.2014
LU01.02.2014
CH28.02.2014
LI28.02.2014
[2017/10]
Former [2016/33]HU01.02.2007
AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
TR01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
IE01.02.2014
LU01.02.2014
CH28.02.2014
LI28.02.2014
Former [2016/32]HU01.02.2007
AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
IE01.02.2014
LU01.02.2014
CH28.02.2014
LI28.02.2014
Former [2015/07]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
IE01.02.2014
LU01.02.2014
CH28.02.2014
LI28.02.2014
Former [2014/46]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
LU01.02.2014
CH28.02.2014
LI28.02.2014
Former [2014/44]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
MC01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
LU01.02.2014
Former [2014/14]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
NL01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2014/11]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
IT01.05.2013
LT01.05.2013
LV01.05.2013
PL01.05.2013
RO01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2014/10]AT01.05.2013
BE01.05.2013
CY01.05.2013
CZ01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
LT01.05.2013
LV01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
SK01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2014/09]AT01.05.2013
BE01.05.2013
CY01.05.2013
DK01.05.2013
EE01.05.2013
FI01.05.2013
LT01.05.2013
LV01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2014/06]AT01.05.2013
BE01.05.2013
CY01.05.2013
FI01.05.2013
LT01.05.2013
LV01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2014/02]AT01.05.2013
CY01.05.2013
FI01.05.2013
LT01.05.2013
LV01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2013/52]AT01.05.2013
CY01.05.2013
FI01.05.2013
LT01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2013/50]AT01.05.2013
FI01.05.2013
LT01.05.2013
PL01.05.2013
SE01.05.2013
SI01.05.2013
BG01.08.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2013/49]AT01.05.2013
FI01.05.2013
LT01.05.2013
SE01.05.2013
SI01.05.2013
GR02.08.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2013/48]AT01.05.2013
LT01.05.2013
ES12.08.2013
IS01.09.2013
PT02.09.2013
Former [2013/47]LT01.05.2013
PT02.09.2013
Documents cited:Search[XY]WO2004064845  (GILEAD SCIENCES INC [US], et al) [X] 17-19 * page 49, paragraph 1 * * page 34, lines 20-31 * * page 25, lines 28-29 * [Y] 13,15;
 [XY]  - WINSTON A ET AL, "The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.", HIV MEDICINE MAY 2005 LNKD- PUBMED:15876286, (200505), vol. 6, no. 3, ISSN 1464-2662, pages 191 - 197, XP002646078 [X] 1-12,14,16,20,21 * page 194, column r, paragraph l; table 1 * * page 196, column l, paragraph 3 * [Y] 13,15
 [XI]  - UPDATE ON EMERGING INFECTIONS: NEWS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION, "Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, Or Other Nonoccupational Exposure to HIV in the United States", ANNALS OF EMERGENCY MEDICINE, LANSING, MI, US, (20050701), vol. 46, no. 1, doi:10.1016/J.ANNEMERGMED.2005.04.005, ISSN 0196-0644, pages 82 - 84, XP004953790 [X] 1-9,11-14,16,20,21 * page 83, column r, paragraph 3 * [I] 10,15,17-19

DOI:   http://dx.doi.org/10.1016/j.annemergmed.2005.04.005
 [XI]  - BUSTER E H C J ET AL, "Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention.", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. SUPPLEMENT 2004 LNKD- PUBMED:15696849, (2004), no. 241, ISSN 0085-5928, pages 45 - 49, XP009149686 [X] 1,2,5,8,9,11,12,20,21 * abstract * [I] 3,4,6
International search[X]WO2005021001  (TIBOTEC PHARM LTD [IE], et al)
Opposition   - SMITH S M, "Pre-exposure chemoprophylaxis for HIV: it is time", RETROVIROLOGY, (20040706), vol. 1, no. 16
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.